Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.440
+0.050 (3.60%)
At close: Dec 20, 2024, 4:00 PM
1.410
-0.030 (-2.08%)
After-hours: Dec 20, 2024, 5:00 PM EST
Outlook Therapeutics Employees
Outlook Therapeutics had 24 employees as of September 30, 2023. The number of employees increased by 7 or 41.18% compared to the previous year.
Employees
24
Change (1Y)
7
Growth (1Y)
41.18%
Revenue / Employee
n/a
Profits / Employee
-$3,918,698
Market Cap
34.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
NeueHealth | 1,252 |
Cumberland Pharmaceuticals | 91 |
Precision Optics Corporation | 85 |
Actinium Pharmaceuticals | 49 |
Surrozen | 42 |
Lantern Pharma | 21 |
NEXGEL | 19 |
Incannex Healthcare | 9 |
OTLK News
- 8 days ago - Outlook Therapeutics® Streamlines Operations - GlobeNewsWire
- 17 days ago - Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD - GlobeNewsWire
- 18 days ago - Outlook Therapeutics® Announces Executive Leadership Transition - GlobeNewsWire
- 24 days ago - Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday? - Benzinga
- 24 days ago - Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial - GlobeNewsWire
- 6 weeks ago - Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series - GlobeNewsWire
- 3 months ago - Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series - GlobeNewsWire